IMR Press / FBL / Special Issues / 1465253094584881153

New Insights into Breast Cancer

Submission deadline: 15 August 2022
Special Issue Editors
  • Nicholas Pavlidis, PhD
    Medical School, University of Ioannina, Stavros Niarchou Avenue, Ioannina, Greece; European School of Oncology, 29 Via Turati, Milan, Italy
    Interests: Cancer of unknown primary; Cancer during pregnancy
  • Stergios Boussios, PhD
    Medway NHS Foundation Trust, Gillingham, Kent, UK; AELIA Organization, Thessaloniki, Greece
    Interests: ovarian cancer; cervical cancer; prostate cancer; renal cancer; colorectal cancer; cancer of unknown primary; cancer during pregnancy; metastatic spinal cord compression
Special Issue Information

Dear Colleagues,

Breast cancer remains one of the most common cancer types in women. It is a heterogeneous disease with a number of molecular phenotypes. Advances in the field of molecular research have offered new insights into the cellular mechanisms and genetic changes that characterize breast cancer subtypes. This has allowed the identification of key driver genes and aberrations that initiate tumor development. Furthermore, the characterization of novel cellular targets has contributed to the development of improved therapeutic and diagnostic strategies.

This Special Issue on "New Insights into Breast Cancer" will gather reviews and original research articles that highlight recent advances in our understanding of the molecular basis of breast cancer, as well as novel therapeutic approaches. We invite researchers working on the personalized management of breast cancer using genomics and other biomarkers to contribute to this Special Issue. Finally, research relating to therapy resistance and novel approaches targeting tumor escape mechanisms will also be included in the scope of this Special Issue.


Prof. Nicholas Pavlidis and Dr. Stergios Boussios

Guest Editors

Keywords
Breast cancer
Personalized medicine
Biomarkers
Cancer stem cells
Circulating tumor cells
Cell signaling
Molecular diagnostics
Molecular profiling
Targeted therapy
Treatment resistance
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2500 USD. Submitted manuscripts should be well formatted in good English.

Published Paper (3 Papers)
Back to top